Publications
- Cost of multiple sclerosis in the Czech Republic: The COMS study2012 | First Faculty of Medicine, Third Faculty of Medicine
- Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis2012 | First Faculty of Medicine
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | First Faculty of Medicine
- Freedom from disease activity in multiple sclerosis2010 | First Faculty of Medicine
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study2009 | First Faculty of Medicine
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL2009 | First Faculty of Medicine
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | First Faculty of Medicine
- The Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a double blind active extension of the multicentre, randomised, double-blind, parallel-group placebo-controlled studyPublication without faculty affiliation
- Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies2024 | First Faculty of Medicine
- Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis2024 | First Faculty of Medicine
Loading network view...
